Name: | Description: | Size: | Format: | |
---|---|---|---|---|
1.08 MB | Adobe PDF |
Advisor(s)
Abstract(s)
Background: Assessment of 2D/3D left ventricular ejection fraction (LVEF) and 2D global longitudinal strain (GLS) is the gold standard for diagnosing cancer therapeutics-related cardiac dysfunction (CTRCD). Although 3D speckle-tracking echocardiography (STE) has several advantages, it is not used in this setting.
Methods: 105 breast cancer patients who underwent serial echocardiographic assessment during anthracycline therapy were included. STE was used to estimate 2D GLS, 3D GLS, 3D global circumferential strain (GCS), 3D global radial strain (GRS), and 3D global area strain (GAS). CTRCD was defined as an absolute decrease in 2D/3D LVEF > 10% to a value < 54% or a relative decrease in 2D GLS > 15%.
Results: 24 patients developed CTRCD. There was a significant worsening of all 3D strain parameters during chemotherapy. 3D strain regional analysis showed impaired contractility in the anterior, inferior, and septal walls. Variations of 3D GRS and 3D GCS were associated with a higher incidence of CTRCD and the variation of 3D GRS was an independent predictor of CTRCD. Variations of 3D GCS and 3D GRS had a good discrimination for predicting CTRCD, with optimal cutoff values of - 34.2% for 3D GCS and - 34.4% for 3D GRS. These variations were observed 45 and 23 days before the diagnosis of CTRCD, respectively.
Conclusion: Variations of 3D strain parameters were predictive of and preceded CTRCD, and thus have added value over currently recommended 2D/3D LVEF and 2D GLS. Routine application of this technique should be considered to offer targeted monitoring and timely initiation of cardioprotective treatment.
Description
Keywords
HSM CAR HSAC ONC Anthracyclines /adverse effects Adult Aged Breast Neoplasms/drug therapy Echocardiography, Three-Dimensional/methods Cardiotoxicity Follow-Up Studies Heart Ventricles/diagnostic imaging Heart Ventricles/ physiopathology Humans Middle Aged Prognosis Stroke Volume/drug effects Prospective Studies Stroke Volume/physiology Stroke Volume/drug effects Ventricular Dysfunction, Left/chemically induced Ventricular Dysfunction, Left/diagnosis Ventricular Dysfunction, Left/physiopathology Ventricular Function, Left/drug effects Ventricular Function, Left/physiology
Citation
Clin Res Cardiol. 2020 Jun;109(6):673-684.
Publisher
SpringerLink